Skip to main content
. Author manuscript; available in PMC: 2009 Jul 1.
Published in final edited form as: Biotechnol Bioeng. 2008 Jul 1;100(4):744–755. doi: 10.1002/bit.21798

Table I.

Details for EGFP-targeting siRNAs experimentally validated in this study*

Start End Antisense Sense GC Content (%)
71 89 ACGCUGAACUUGUGGCCGU ACGGCCACAAGUUCAGCGU1 52
81 99 CUCGCCGGACACGCUGAAC GUUCAGCGUGUCCGGCGAG 62
126 144 GAUGAACUUCAGGGUCAGC GCUGACCCUGAAGUUCAUC1 48
159 177 GGGCCAGGGCACGGGCAGC GCUGCCCGUGCCCUGGCCC 76
274 292 UGCGCUCCUGGACGUAGCC GGCUACGUCCAGGAGCGCA 62
306 324 CUUGUAGUUGCCGUCGUCC GGACGACGGCAACUACAAG 52
318 336 CUCGGCGCGGGUCUUGUAG CUACAAGACCCGCGCCGAG 62
396 414 CAGGAUGUUGCCGUCCUCC GGAGGACGGCAACAUCCUG 57
441 459 GAUAUAGACGUUGUGGCUG CAGCCACAACGUCUAUAUC 43
471 489 CUUGAUGCCGUUCUUCUGC GCAGAAGAACGGCAUCAAG 48
495 513 GUUGUGGCGGAUCUUGAAG CUUCAAGAUCCGCCACAAC 48
501 519 CUCGAUGUUGUGGCGGAUC GAUCCGCCACAACAUCGAG 52
558 576 GCCGUCGCCGAUGGGGGUG CACCCCCAUCGGCGACGGC 71
597 615 CUGGGUGCUCAGGUAGUGG CCACUACCUGAGCACCCAG 57
639 657 CAUGUGAUCGCGCUUCUCG CGAGAAGCGCGAUCACAUG 52
*

Start sites are relative to the start codon of the EGFP coding sequence. GC Content is per 21 nt.

1

siRNA sequences obtained from (Kim and Rossi, 2003).